| Catalog_no |
ADMC0349 |
| Product_name |
Omipalisib(GSK-458) |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
1780.00/4660.00/8400.00 |
| Specificity |
Target: PI3K. Fields: GSK2126458 is a highly selective and potent inhibitor of PI3K with Ki of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM for p110α/β/δ/γ, mTORC1/2 , respectively. Ki: 0.019 nM (p110α), 0.13 nM (p110β), 0.024 nM (p110δ), 0. |
| Dilution |
Ki: 0.019 nM (p110α), 0.13 nM (p110β), 0.024 nM (p110δ), 0.06 nM (p110γ), 0.18 nM (mTORC1), 0.3 nM (mTORC2) |
| Purification |
>98% |
| Concentration |
靶点：PI3K;IC50：Ki: 0.019 nM (p110α), 0.13 nM (p110β), 0.024 nM (p110δ), 0.06 nM (p110γ), 0.18 nM (mTORC1), 0.3 nM (mTORC2) |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
GSK212; GSK-2126458; GSK 2126458; GSK-212; GSK 212，GSK458，GSK 458,GSK2126458 |
| Molecular Weight |
505.5 |
| Notes |
GSK2126458 is a highly selective and potent inhibitor of PI3K with Ki of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM for p110α/β/δ/γ, mTORC1/2 , respectively. Ki: 0.019 nM (p110α), 0.13 nM (p110β), 0.024 nM (p110δ), 0.06 nM (p110γ), 0.18 nM |
| Instructions |
 查看与下载 |
